BMS-986278是一种具有高效口服活性的血磷脂酸受体 1 (LPA1) 拮抗剂,其对人类和小鼠 LPA1 的 Kb 值分别为 6.9 nM 和 4.0 nM。该化合物被认为在肺纤维化相关疾病的研究中具有潜在应用价值。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | BMS-986278 exhibits significant potency and oral bioavailability as an antagonist of lysophosphatidic acid receptor 1 (LPA1), with affinity constants (Kb) of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively. Its potential application in the study of pulmonary fibrotic diseases is noteworthy[1]. |
体内研究 | BMS-986278 (0.1-10 mg/kg; a single pO.) also completely inhibits LPA-stimulated systemic histamine release in a concentration-dependent manner in CD1 mice[1]. BMS-986278 (3-30 mg/kg; orally administered twice daily for 14 days) reduces Bleomycin-induced collagen deposition and lung fibrosis in rats[1]. |
体外研究 | BMS-986278 is characterized as a high-affinity antagonist of Lysophosphatidic acid receptor 1 (LPA1), exhibiting affinity constants (Kb) of 6.9 nM and 4.0 nM for human and mouse LPA1, respectively, in CHO cells that overexpress LPA1[1]. BMS-986278 antagonizes Lysophosphatidic acid (LPA)-stimulated calcium flux in normal human lung fibroblasts, with a Kb of 5.8 nM. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.24mL 0.45mL 0.22mL |
11.22mL 2.24mL 1.12mL |
22.45mL 4.49mL 2.24mL |
CAS号 | 2170126-74-4 |
分子式 | C22H31N5O5 |
分子量 | 445.512 |
别名 | |
运输 | 蓝冰 |
存储条件 |
粉末 Inert atmosphere,Store in freezer, under -20°C 液体 -20°C:3-6个月-80°C:12个月 |
溶解度 |
DMSO: 105 mg/mL(235.68 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |